Chinese expert consensus on postoperative follow-up for non-small cell lung cancer (version 2025)
- VernacularTitle:非小细胞肺癌术后随访中国胸外科专家共识（2025版）
- Author:
Lunxu LIU
1
;
Shugeng GAO
2
;
Jianxing HE
3
;
Jian HU
4
;
Di GE
5
;
Hecheng LI
6
;
Mingqiang KANG
7
;
Fengwei TAN
8
;
Fan YANG
9
;
Qiang PU
1
;
Kaican CAI
10
Author Information
1. Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
2. epartment of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, P. R. China
3. Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, P. R. China
4. Department of General Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, P. R. China
5. Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China
6. Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, P. R. China
7. Department of Thoracic Surgery, Union Hospital, Fujian Medical University, Fuzhou, 350001, P. R. China
8. Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, P. R. China
9. Department of Thoracic Surgery, Peking University People s Hospital, Beijing, 100044, P. R. China
10. Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, P. R. China
- Collective Name:Chinese Medical Doctor Association Thoracic Surgeons Branch, Thoracic Surgery Society of China Medical Education Association
- Publication Type:Journal Article
- Keywords:
Non-small cell lung cancer;
postoperative follow-up;
thoracic surgery;
expert consensus
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2025;32(03):281-290
- CountryChina
- Language:Chinese
-
Abstract:
Surgical treatment is one of the key approaches for non-small cell lung cancer (NSCLC). Regular postoperative follow-up is crucial for early detection and timely management of tumor recurrence, metastasis, or second primary tumors. A scientifically sound and reasonable follow-up strategy not only extends patient survival but also significantly improves quality of life, thereby enhancing overall prognosis. This consensus aims to build upon the previous version by incorporating the latest clinical research advancements and refining postoperative follow-up protocols for early-stage NSCLC patients based on different treatment modalities. It provides a scientific and practical reference for clinicians involved in the postoperative follow-up management of NSCLC. By optimizing follow-up strategies, this consensus seeks to promote the standardization and normalization of lung cancer diagnosis and treatment in China, helping more patients receive high-quality care and long-term management. Additionally, the release of this consensus is expected to provide insights for related research and clinical practice both domestically and internationally, driving continuous development and innovation in the field of postoperative management for NSCLC.
